Phase II study of bevacizumab (B) plus cisplatin (C) plus intensity-modulated radiation therapy (IMRT) for locoregionally advanced head and neck squamous cell cancer (HNSCC): Preliminary results Meeting Abstract


Authors: Pfister, D. G.; Lee, N. Y.; Sherman, E.; Lisa, D.; Carlson, D.; Stambuk, H.; Shen, R.; Kraus, D.; Shah, J.; Fury, M. G.
Abstract Title: Phase II study of bevacizumab (B) plus cisplatin (C) plus intensity-modulated radiation therapy (IMRT) for locoregionally advanced head and neck squamous cell cancer (HNSCC): Preliminary results
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 304s
Language: English
ACCESSION: WOS:000276606604219
PROVIDER: wos
DOI: 10.1200/jco.2009.27.15_suppl.6013
Notes: Meeting Abstract: 6013 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dennis Kraus
    268 Kraus
  2. Diane Carlson
    52 Carlson
  3. Eric J Sherman
    339 Sherman
  4. Ronglai Shen
    204 Shen
  5. Hilda Stambuk
    48 Stambuk
  6. Nancy Y. Lee
    871 Lee
  7. David G Pfister
    389 Pfister
  8. Matthew G Fury
    102 Fury
  9. Jatin P Shah
    721 Shah
  10. Donna Lisa
    13 Lisa